Trial · NCT04908683
Adverse events1,204
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,204
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea(Solicited) | Gastrointestinal disorders | Group 1: Ad26.RSV.preF and RSV preF Protein | 324 | 2,330 | 324 |
| other | Nausea(Solicited) | Gastrointestinal disorders | Group 2: Placebo | 75 | 1,165 | 75 |
| other | Fatigue(Solicited) | General disorders | Group 1: Ad26.RSV.preF and RSV preF Protein | 789 | 2,330 | 789 |
| other | Fatigue(Solicited) | General disorders | Group 2: Placebo | 165 | 1,165 | 165 |
| other | Pain | General disorders | Group 1: Ad26.RSV.preF and RSV preF Protein | 48 | 2,330 | 61 |
| other | Pain | General disorders | Group 2: Placebo | 12 | 1,165 | 18 |
| other | Pyrexia(Solicited) | General disorders | Group 1: Ad26.RSV.preF and RSV preF Protein | 171 | 2,330 | 171 |
| other | Pyrexia(Solicited) | General disorders | Group 2: Placebo | 5 | 1,165 | 5 |
| other | Vaccination Site Erythema(Solicited) | General disorders | Group 1: Ad26.RSV.preF and RSV preF Protein | 63 | 2,330 | 63 |
| other | Vaccination Site Erythema(Solicited) | General disorders | Group 2: Placebo | 5 | 1,165 | 5 |
| other | Vaccination Site Pain(Solicited) | General disorders | Group 1: Ad26.RSV.preF and RSV preF Protein | 1,065 | 2,330 | 1,065 |
| other | Vaccination Site Pain(Solicited) | General disorders | Group 2: Placebo | 168 | 1,165 | 168 |
| other | Vaccination Site Swelling(Solicited) | General disorders | Group 1: Ad26.RSV.preF and RSV preF Protein | 68 | 2,330 | 68 |
| other | Vaccination Site Swelling(Solicited) | General disorders | Group 2: Placebo | 3 | 1,165 | 3 |
| other | Blood Pressure Diastolic Increased | Investigations | Group 1: Ad26.RSV.preF and RSV preF Protein | 58 | 2,330 | 58 |
| other | Blood Pressure Diastolic Increased | Investigations | Group 2: Placebo | 21 | 1,165 | 21 |
| other | Blood Pressure Systolic Increased | Investigations | Group 1: Ad26.RSV.preF and RSV preF Protein | 150 | 2,330 | 150 |
| other | Blood Pressure Systolic Increased | Investigations | Group 2: Placebo | 60 | 1,165 | 60 |
| other | Respiratory Rate Increased | Investigations | Group 1: Ad26.RSV.preF and RSV preF Protein | 89 | 2,330 | 89 |
| other | Respiratory Rate Increased | Investigations | Group 2: Placebo | 49 | 1,165 | 49 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04908683/events